Form 4: Vaxcyte CEO Grant Pickering Reports Gift of Shares and Beneficial Ownership

Vaxcyte CEO Grant Pickering reported a gift of 710 common shares and details of beneficial ownership including shares held in trust for his children.

Summary

• Grant Pickering, CEO of Vaxcyte, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• The filing reports a gift of 710 common shares to a non-profit educational institution through a donor-advised fund.
• Following the transaction, Pickering directly owns 465,301 common shares.
• Additionally, he indirectly owns 137,398 shares through a trust for his daughter and another 137,398 shares through a trust for his son.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing and does not indicate any positive or negative sentiment.

Industry Context

Form 4 filings are a standard part of regulatory compliance for company insiders, providing transparency into their transactions and holdings of company stock.

Comparison to Industry Standards

• Form 4 filings are a common practice for publicly traded companies, and the details provided in this filing are consistent with standard reporting requirements.
• Other biotech companies such as Moderna (MRNA) and BioNTech (BNTX) also have similar filings when their executives trade shares.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the CEO's stock transactions and holdings.

Key Dates

Keywords

Form 4, Beneficial Ownership, Vaxcyte, Grant Pickering, Stock Gift, Executive Ownership, PCVX